Questcor downgraded to Market Perform from Outperform at Leerink Leerink downgraded Questcor citing increased Acthar reimbursement risk. The firm has a $35 price target for shares.
News For QCOR From The Last 14 Days
Check below for free stories on QCOR the last two weeks.